Dynamic changes in lymphocyte GRK2 levels in cardiac transplant patients: A biomarker for left ventricular function

Clinical and Translational Science

Volumn 3, Issue 1, 2010, Pages 14-18

  Bonita, Raphael E ^a   Raake, Philip W ^b   Otis, Nicholas J ^b   Chuprun, J Kurt ^b   Spivack, Talya ^a   Dasgupta, Abhijit ^a   Whellan, David J ^a   Mather, Paul J ^a   Koch, Walter J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Biomarkers; GRK2; Heart failure; Heart transplantation

Indexed keywords

BIOLOGICAL MARKER; G PROTEIN COUPLED RECEPTOR KINASE 2;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMODYNAMICS; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; HEART FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDIUM; VENTRICULAR FUNCTION, LEFT;

EID: 77953366234     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2010.00176.x     Document Type: Article

References (13)

1. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008, 358:2148-2149.
2. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature. 2002, 415:206-212.
3. Hata JA, William ML, Koch WJ. Genetic manipulation of myocardial b-adrenergic receptor activation and desensitization. J Mol Cell Cardiol. 2004, 37:11-21.
4. Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of b-adrenergic receptor kinase and b1-adrenergic receptors in the failing human heart. Circulation. 1993, 87:454-463.
5. Iaccarino G, Barbato E, Cipolletta E, De Amicis V, Margulies KB, Leosco D, Trimarco B, Koch WJ. Elevated myocardial and blood GRK2 expression and activity in human heart failure. Eur Heart J. 2005, 26:1752-1758.
6. Hata JA, Williams ML, Schroder JN, Lima B, Keys JR, Blaxall BC, Petrofski JA, Jakol A, Milano CA, Koch WJ. Lymphocyte levels of GRK2 (βARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved β-adrenergic signaling after mechanical unloading. J Card Fail. 2006, 12:360-368.
7. Kherani A, Maybaum S, Oz M. Ventricular assist devices as a bridge to transplant or recovery. Cardiology. 2004, 101:93-103.
8. Brodde OE, Kretsch R, Ikezono K, Zerkowski HR, Reidemeister JC. Human beta-adrenoreceptors: relation of myocardial and lymphocyte beta-adrenoreceptor density. Science. 1986, 231:1584-1585.
9. Bristow MR, Larrabee P, Muller-Beckmann B, Minobe W, Roden R, Skerl L, Klein J, Handerger D, Port JD. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. Clin Investig. 1992, 70:S105-S113.
10. Dzimiri N, Moorji A. Relationship between alterations in lymphocyte and myocardial beta-adrenoceptor density in patients with left heart valvular disease. Clin Exp Pharmacol Physiol. 1996, 23:498-502.
11. Raake P, Vinge LE, Gao E, Boucher M, Rengo G, Chen X, DeGeorge BR, Matkovich S, Houser SR, Most P, Eckhart AD, Dorn GW, Koch WJ. G protein-coupled receptor kinase 2 ablation in cardiac myo-cytes before or after myocardial infarction prevents heart failure. Circ Res. 2008, 103:413-422.
12. Rengo G, Lymperopoulos A, Zincarelli C, Donniacuo M, Soltys S, Rabinowitz JE, Koch WJ. Myo-cardial adeno-associated virus serotype-6-bARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation. 2009, 119:89-98.
13. Mak JC, Hisada T, Salmon M, Barnes PJ, Chung KF. Glucocorticoids reverse IL-1β-induced impairment of β-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases. Br J Pharmacol. 2002, 135:987-996.